Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Endo ... watching just for fun
View:
Post by MrMugsy on May 09, 2022 11:52am

Endo ... watching just for fun

It is for no other reason than for "fun" that we watch the demise of Paladin's acquirer - Endo.
Also ... to see if GUD makes any kind of play for their 69 Canadian drugs.  The price is likely not right - but - fun to watch anyway.

It was obvious back then that using debt to run a series of acquisitions was not a good idea for the long-term.

The market cap of Endo is now $332M and debt totals approximately $8 Billion ... Seeking Alpha may have been on to something in their comments back in August 2021 ...


  • With a weak balance sheet, lingering opioid lawsuits and the upcoming threat of a generic vasopressin competitor, the likelihood of a bankruptcy announcement in the coming months is high.

Endo has been fighting hard - but for how long?  The opioid crisis will surely do them in.  Did Seeking Alpha make the right call?  Will see.


With the recent announcement of the hiring of a restructuring adviser, I believe Endo is likely on its last legs and will follow the path of its peer, Mallinckrodt (MNK), i.e. into Chapter 11 bankruptcy filing.



  •  
Comment by GoldenInvestor on May 09, 2022 12:25pm
I see Endo's market cap at $282.13 Million, on CNBC!! stock price at $1.20.
Comment by MrMugsy on May 09, 2022 2:03pm
No idea how they continue like this - going to have to shed assets and/or restructure. A decision on what to do can't be that far away.
Comment by longrun86 on May 10, 2022 1:10pm
Out of curiosity I looked at the recent Presentation and earnings releases. The summation is simple: Endo is a Zombie. All shareholder value has been destroyed. The debt holders are in control now. Goodman and his team must be sad to see everything they worked for at Paladin in this state I think you guys who are around from the Paladin days might have a view as to if there is anything for Knight ...more  
Comment by MrMugsy on May 10, 2022 7:15pm
About 69 Canadian drugs they would take off Endo's hands (only thing left in Endo International)  - but - only if they can get it on the cheap. The LATAM assets were already sold off - which I think came via other deals and mostly unrelated to Paladin anyway (don't quote me on that - lots of amalgamation when Paladin was acquired). Ya - what happened at Endo is depressing (on one ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities